FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

4847311000001104: Cancidas 50mg powder for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1732381000001117 Cancidas 50mg powder for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1732391000001115 Cancidas 50mg powder for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cancidas 50mg powder for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cancidas 50mg powder for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Is a Caspofungin 50mg powder for solution for injection vials true Inferred relationship Existential restriction modifier
Cancidas 50mg powder for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Cancidas 50mg powder for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cancidas 50mg powder for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Has active ingredient Caspofungin acetate false Inferred relationship Existential restriction modifier
Cancidas 50mg powder for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cancidas 50mg powder for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Cancidas 50mg powder for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Has manufactured dose form Powder for conventional release solution for injection false Inferred relationship Existential restriction modifier
Cancidas 50mg powder for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Is a Cancidas true Inferred relationship Existential restriction modifier
Cancidas 50mg powder for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Caspofungin true Inferred relationship Existential restriction modifier
Cancidas 50mg powder for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Has specific active ingredient Caspofungin acetate true Inferred relationship Existential restriction modifier
Cancidas 50mg powder for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Has active ingredient Caspofungin true Inferred relationship Existential restriction modifier
Cancidas 50mg powder for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Has dispensed dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
Cancidas 50mg powder for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Cancidas 50mg powder for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Has manufactured dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
Cancidas 50mg powder for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Has basis of strength substance Caspofungin true Inferred relationship Existential restriction modifier
Cancidas 50mg powder for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Has dispensed dose form Powder for conventional release solution for infusion true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Cancidas 50mg powder for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) 1 vial Is pack of False Cancidas 50mg powder for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Inferred relationship Existential restriction modifier
Cancidas 50mg powder for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) 1 vial Has AMP True Cancidas 50mg powder for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start